Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2007
11/29/2007US20070275985 Triazolopyrimidines
11/29/2007US20070275969 Nanoparticles for oral administration of pharmaceutical agents of low solubility
11/29/2007US20070275962 Heterobicyclic Compounds as Pharmaceutically Active Agents
11/29/2007US20070275954 Novel Fused Heterocycles and Uses Thereof
11/29/2007US20070275953 2-Pyridinone Derivatives, Having Hiv Inhibiting Properties
11/29/2007US20070275919 Rna Amidates and Thioamidates for Rnai
11/29/2007US20070275912 Nucleoside derivatives as inhibitors of rna-dependent RNA viral polymerase
11/29/2007US20070275903 oligopeptide conjugates; cleavable by trouase such as Thimet oligopeptidase; antitumor agents
11/29/2007US20070275898 processivity clamp factor of DNA polymerase and a peptide comprising all or part of the processivity clamp factor binding sequence of a processivity clamp factor interacting protein; uses, in particular for the screening, the design or the modification of ligands
11/29/2007US20070275884 Use of modified cyclosporins for the treatment of hcv disorders
11/29/2007US20070275879 Use of Ulinastatin and Its Pharmaceutical Composition for Treating Severe Acute Respiratory Syndrome
11/29/2007US20070275877 Methods for Treating or Ameliorating Ghrelin-Associated Diseases and Disorders
11/29/2007US20070275436 polypeptide comprising an amino acid sequence having polyene polyketide synthase activity; involved in the biosynthesis of novel polyketides, inhibitors of fungal cell growth and cancer cell growth
11/29/2007US20070275013 Vaccine and Method of Use
11/29/2007US20070275012 Pharmaceutical Compositions for Therapeutic Use
11/29/2007US20070275010 Mva Vaccines
11/29/2007US20070275004 Group b streptococcus antigens
11/29/2007US20070275002 Use Of Proteins And Peptides Encoded By The Genome Of A Novel Sars-Associated Coronavirus Strain
11/29/2007US20070275000 Tick Engorgement Factor Proteins
11/29/2007US20070274998 Novel Bispecific Molecules For Use In Therapy And Diagnosis
11/29/2007US20070274974 Compositions and methods for restoring immune responsiveness in patients with immunological defects
11/29/2007US20070274973 Method of controlling fungal pathogens, and agents useful for same
11/29/2007US20070274951 Combinations comprising HCV protease inhibitor(s) and HCV polymerase inhibitor(s), and methods of treatment related thereto
11/29/2007DE19531342B4 Verwendung von Aminoadamantan-Verbindungen als Immunregulatoren Use of aminoadamantane compounds as immune regulators
11/29/2007CA2652857A1 Crystalline a and b forms of a maleate salt of 5-amino-3- (2 ', 3 '-di-o-acetyl-beta-d-ribofuranosyl) -3h-thiazolo [4, 5-d] pyrimidin-2-one
11/29/2007CA2652841A1 New benzothiazinone derivatives and their use as antibacterial agents
11/29/2007CA2652576A1 Methods and compositions for the treatment of viral infections
11/29/2007CA2652559A1 Biotherapeutic compositions and uses thereof
11/29/2007CA2651690A1 Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors
11/28/2007EP1860192A1 Compositions and methods for treating intracellular diseases
11/28/2007EP1860191A2 Combination neisserial compositions
11/28/2007EP1860190A2 Neutrokine-alpha and neutrokine-alpha splice variants
11/28/2007EP1860117A2 Anti-bacterial vaccine compositions
11/28/2007EP1858923A1 A molecule and chimeric molecules thereof
11/28/2007EP1858917A2 Varicella zoster virus vaccine
11/28/2007EP1858889A1 Bicyclic nucleosides and nucleotides as therapeutic agents
11/28/2007EP1858887A1 Piperidinyl piperazine derivatives useful as inhibitors of chemokine receptors
11/28/2007EP1858886A1 Piperidinyl piperidine derivatives useful as inhibitors of chemokine receptors
11/28/2007EP1858861A1 Hiv inhibiting 2-(4-cyanophenyl)-6-hydroxylaminopyrimidines
11/28/2007EP1858531A1 Use of copper silicate for the control of herpes infections
11/28/2007EP1858510A1 Antifungal compositions comprising sertaconazol and hydrocortisone and/or an antibacterial quinolone compound
11/28/2007EP1858506A2 Methods of treating ear infections
11/28/2007EP1858482A2 Methods of reducing microbial contamination
11/28/2007EP1737862A4 Imidazopyridine compound
11/28/2007EP1539224B1 Antimicrobial composition and method for use
11/28/2007EP1534674A4 Cytotoxic agents containing novel potent taxanes and their therapeutic use
11/28/2007EP1412486B1 Method for virus propagation
11/28/2007EP1328245B1 Dental care compositions
11/28/2007CN101080418A Tripeptide and tetrapeptide sulfones
11/28/2007CN101080413A Silicon compounds and their use
11/28/2007CN101080230A Treatment and control of severe infections including cystic fibrosis
11/28/2007CN101080221A Parenteral combination therpy for infective conditions with drug resistant bacterium
11/28/2007CN101077875A Boronic ester and acid compounds, synthesis and uses
11/28/2007CN101077869A Crystalline 1-methylcarbapenem compound
11/28/2007CN101077868A Thiadiazoles substituted imidazoles anti-anaerobe compounds
11/28/2007CN101077866A Substituted benzoxazoles antifungal compounds and preparation method thereof
11/28/2007CN101077858A Method for preparing butenafine hydrochloride
11/28/2007CN101077410A Method for treating gastric flu
11/28/2007CN101077409A Medicament for preventing and treating rabies and a set of simple medical apparatus
11/28/2007CN101077408A Oil of aromatic turmeric gel for ocular application and its production process
11/28/2007CN101077406A Traditional Chinese medicine for preventing and treating acquired immuno-deficiency syndrome and its preparing process
11/28/2007CN101077385A Method for treating influenza
11/28/2007CN101077380A Antivirus medicinal composition and preparation method thereof
11/28/2007CN101077378A Medicinal composition for treating virus infection of respiratory tract and preparation method thereof
11/28/2007CN101077371A Method for treating wind-cold common cold
11/28/2007CN101077362A Plant-type skin mucosa disinfecting agent
11/28/2007CN101077356A Application for polysaccharide extraction of grateloupia filicina in preparing antitumor medicine and other medicines
11/28/2007CN101077351A Soft capsules containing roxithromycin
11/28/2007CN101077348A Amoxicillin-clavulantes sustained release tablets
11/28/2007CN101077333A External applied gel with butenafine hydrochloride as principal ingredient
11/28/2007CN101077181A Oral cavity detoxifcation porridge
11/28/2007CN101077174A Tea soup with indigestion and stomach nourishing health function
11/28/2007CN101077149A Bean product with keeping from catching cold function and its manufacturing method
11/28/2007CN101077101A Purple perilla and ledebouriella root tea
11/28/2007CN100351385C Herpes viruses for immune modulation
11/28/2007CN100351271C Active polypeptide of brown-spotted torrential frog, its gene and application in drug preparation
11/28/2007CN100351270C Antibacterial peptide of brown-spotted torrential frog, its gene and application in drug preparation
11/28/2007CN100351264C Antiviral nucleoside derivatives
11/28/2007CN100351259C Sulfur-containing phospholipid derivatives
11/28/2007CN100351258C Crystals of quinolinecarboxylic acid derivative solvate.
11/28/2007CN100351255C Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic
11/28/2007CN100351245C Oxa- and thiadiazoles and their use as metalloproteinase inhibitors
11/28/2007CN100351244C Bis-aromatic alkanols
11/28/2007CN100351238C New derivatives of erythromycin, their preparation process and their use as medicaments
11/28/2007CN100351222C Rheinic acid preparing process
11/28/2007CN100350976C Reversible gelling system for ocular drug delivery
11/28/2007CN100350972C Vaccines comprising aluminium adjuvants and histidine
11/28/2007CN100350953C Medicinal composition for treating high fever due to virus infection and its preparation method
11/28/2007CN100350943C Medicinal composition for treating hepatitis B and preparation method thereof
11/28/2007CN100350910C Method for preparing freeze dried cefathiamidine
11/28/2007CN100350907C Natural antioxidant with human immunity-enhancing and virus-preventing functions
11/28/2007CN100350904C Coronavirus inactivating agent
11/28/2007CN100350897C Two-phase hard capsule and its application
11/27/2007US7301037 Charged compounds comprising a nucleic acid binding moiety and uses therefor
11/27/2007US7301024 Crystalline forms of gatifloxacin and processes for preparation
11/27/2007US7301005 Immunomodulatory peptides derived from heat shock proteins and uses thereof
11/27/2007US7300952 NF-κb inhibitors
11/27/2007US7300942 For therapy of a fungal infection
11/27/2007US7300921 with antibiotic activity; made by cultivation of Amycolatopsis orientalis
11/27/2007US7300670 Oral suspension formulation